Intriguingly, the OS of younger Black AML patients in contrast to White patients was not improved by NPM1 mutations, even though this measure was adversely affected by FLT3-ITD and IDH2 mutations [28]. The gene discussed is IDH2; the disease is acute myeloid leukemia.